发明授权
US07294631B2 Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives
失效
取代的8'-吡啶(MI)二乙基 - 二氢螺环 - [环烷基胺] - 嘧啶并[1,2-a]嘧啶-6-酮衍生物
- 专利标题: Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives
- 专利标题(中): 取代的8'-吡啶(MI)二乙基 - 二氢螺环 - [环烷基胺] - 嘧啶并[1,2-a]嘧啶-6-酮衍生物
-
申请号: US11423557申请日: 2006-06-12
-
公开(公告)号: US07294631B2公开(公告)日: 2007-11-13
- 发明人: Nathalie Chereze , Alistair Lochead , Mourad Saady , Franck Slowinski , Philippe Yaiche
- 申请人: Nathalie Chereze , Alistair Lochead , Mourad Saady , Franck Slowinski , Philippe Yaiche
- 申请人地址: FR Paris JP Osaka
- 专利权人: Sanofi-Aventis,Mitsubishi Pharma Corporation
- 当前专利权人: Sanofi-Aventis,Mitsubishi Pharma Corporation
- 当前专利权人地址: FR Paris JP Osaka
- 代理商 Balaram Gupta
- 主分类号: A61K31/527
- IPC分类号: A61K31/527 ; A61K31/551 ; C07D225/08 ; C07D239/20 ; C07D487/20 ; C07D495/10
摘要:
The invention relates to a dihydrospiro-[cycloalkylamine]-pyrimidone derivative represented by formula (I) or a salt thereof: wherein X, Y, R1, R2, R3, R4, o, m, n, p and q are as defined herein. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β, such as Alzheimer disease.
公开/授权文献
信息查询
IPC分类: